CD38 (Clusters of Differentiation 38) inhibitors
- Name
- CD38 (Clusters of Differentiation 38) inhibitors
- Accession Number
- DBCAT005752
- Description
Not Available
- ATC Classification
- Drugs
Drug Drug Description Daratumumab A CD38-directed cytolytic antibody used alone or as an adjunct drug in the treatment of multiple myeloma and light chain amyloidosis. Isatuximab A chimeric monoclonal antibody targeted against surface CD38 glycoproteins for the treatment of multiple myeloma in patients who have failed previous therapies. - Drugs & Drug Targets
Drug Target Type Daratumumab ADP-ribosyl cyclase 1 target Isatuximab ADP-ribosyl cyclase 1 target